Reply to Cortegiani and Giarratano, "Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?"

Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00891-18. doi: 10.1128/AAC.00891-18. Print 2018 Jul.
No abstract available

Keywords: antifungal agents; trial sequential analysis; untargeted treatment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifungal Agents*
  • Critical Illness
  • Economics, Pharmaceutical
  • Humans
  • Mycoses*
  • Network Meta-Analysis

Substances

  • Antifungal Agents